Our Pricing

Avanafil vs Viagra: Which Erectile Dysfunction Treatment Works Best for You?

Published: 18 August 2026

When comparing avanafil vs Viagra for erectile dysfunction treatment, understanding the key differences in onset time, duration, and side effect profiles helps you make an informed choice. Both medications belong to the PDE5 inhibitor class and work by increasing blood flow to the penis, but avanafil (marketed as Spedra) offers a faster onset of action whilst Viagra (sildenafil) provides a longer-established track record. As UK-registered pharmacists who have supported thousands of patients through erectile dysfunction treatment, we've compiled this evidence-based comparison to help you determine which option aligns best with your lifestyle and clinical needs.

How Avanafil vs Viagra Work: Mechanism of Action Explained

Both avanafil and Viagra function as selective phosphodiesterase type 5 (PDE5) inhibitors, blocking the enzyme that breaks down cyclic guanosine monophosphate (cGMP) in penile tissue [1]. When sexual stimulation occurs, increased cGMP levels relax smooth muscle cells in the corpus cavernosum, allowing enhanced blood flow and facilitating an erection. The fundamental mechanism remains identical between avanafil vs Viagra, but their molecular structures create important pharmacokinetic differences.

Avanafil demonstrates higher selectivity for the PDE5 enzyme compared to other phosphodiesterase subtypes, which may contribute to its reduced side effect profile in clinical studies [2]. Viagra, as the first PDE5 inhibitor approved for erectile dysfunction in 1998, has accumulated extensive real-world safety data across diverse patient populations. Both medications require sexual arousal to be effective—they do not create spontaneous erections but rather enhance the natural erectile response when stimulation is present.

Avanafil vs Viagra: Onset Time and Duration Comparison

The most clinically significant distinction when evaluating avanafil vs Viagra lies in their pharmacokinetic profiles. Avanafil reaches peak plasma concentrations in approximately 30-45 minutes, with some patients reporting effective results as early as 15 minutes after administration [3]. This rapid onset makes avanafil particularly suitable for patients seeking spontaneity in sexual activity without extensive advance planning.

Viagra typically requires 60 minutes to reach therapeutic levels, though fatty meals can delay absorption further. The duration of action also differs: avanafil maintains effectiveness for approximately 4-6 hours, whilst Viagra's therapeutic window extends to 4-5 hours [4]. Neither medication should be taken more than once daily, and both require clinical assessment by a UK prescriber before use.

Food Interactions: Avanafil vs Viagra

Avanafil demonstrates minimal food interaction, with high-fat meals causing only modest delays in absorption without significantly reducing efficacy. Viagra's absorption is notably impaired by fatty foods, which can delay onset by up to an hour and reduce peak plasma concentrations by approximately 29% [1]. For patients who prefer taking erectile dysfunction medication around mealtimes, avanafil offers greater flexibility and predictability in clinical response.

Side Effects Profile: Avanafil vs Viagra Safety Comparison

When comparing avanafil vs Viagra for tolerability, clinical trial data reveals subtle but important differences in adverse event frequencies. The most common side effects shared by both medications include headache, facial flushing, nasal congestion, and dyspepsia [5]. However, avanafil's enhanced PDE5 selectivity appears to correlate with lower incidence rates of visual disturbances and back pain compared to sildenafil.

In pivotal trials, headache occurred in approximately 10-12% of avanafil users versus 15-16% for Viagra, whilst visual disturbances affected fewer than 1% of avanafil patients compared to 2-3% with sildenafil [6]. Both medications carry contraindications for concurrent nitrate use due to potentially dangerous blood pressure reductions. Patients with cardiovascular conditions, hepatic impairment, or those taking CYP3A4 inhibitors require dose adjustments and careful monitoring regardless of which PDE5 inhibitor is selected.

Contraindications Shared by Avanafil vs Viagra

Both avanafil and Viagra are absolutely contraindicated in patients taking nitrate medications for angina, as the combination can precipitate life-threatening hypotension. Alpha-blocker use requires cautious dose titration, and patients with severe cardiovascular disease should undergo thorough cardiac assessment before starting either treatment. Our UK-registered clinical team evaluates these risk factors during the mandatory online consultation to ensure safe prescribing aligned with MHRA guidelines.

Dosing Strategies: Avanafil vs Viagra Starting Doses

Standard starting doses differ between avanafil vs Viagra based on their pharmacokinetic profiles and clinical trial outcomes. Avanafil is typically initiated at 100mg taken approximately 15-30 minutes before anticipated sexual activity, with adjustments to 50mg (for tolerability) or 200mg (for efficacy) based on individual response [7]. Viagra's standard starting dose is 50mg taken one hour before sexual activity, adjustable to 25mg or 100mg depending on effectiveness and side effect tolerance.

Both medications should be taken on an as-needed basis rather than daily, with a maximum frequency of once per 24-hour period. Patients over 65 years or those with hepatic or renal impairment may require lower starting doses. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all dose recommendations account for patient-specific factors including age, comorbidities, and concurrent medications during the clinical assessment process.

Clinical Efficacy: Avanafil vs Viagra Success Rates

When evaluating avanafil vs Viagra for clinical effectiveness, both medications demonstrate robust efficacy in treating erectile dysfunction across severity levels. Avanafil achieved successful intercourse rates of 57-59% in patients with moderate to severe ED compared to 27% with placebo in pivotal trials [3]. Viagra has shown success rates ranging from 62-82% depending on dose and ED severity, with extensive real-world data supporting these findings over more than two decades of clinical use [8].

The International Index of Erectile Function (IIEF) scores improved significantly with both treatments, though direct head-to-head comparisons remain limited in published literature. Patient preference studies suggest that faster onset time with avanafil appeals to those prioritising spontaneity, whilst Viagra's longer market presence provides reassurance for patients who value established safety profiles. Individual response varies considerably, and some patients may need to trial both medications under prescriber supervision to identify their optimal treatment.

Special Populations: Diabetes and Cardiovascular Disease

Both avanafil and Viagra demonstrate maintained efficacy in patients with diabetes mellitus and controlled cardiovascular disease, though success rates may be modestly lower than in otherwise healthy populations [5]. Diabetic neuropathy and vascular complications can reduce treatment response regardless of which PDE5 inhibitor is used. Our clinical team conducts thorough cardiovascular risk stratification during consultation to ensure safe prescribing in these higher-risk groups, in accordance with NICE guidance on erectile dysfunction management.

UK Pricing and Accessibility: Avanafil vs Viagra Cost Comparison

Cost considerations play an important role when choosing between avanafil vs Viagra in the UK market. At Cured Pharmacy, Viagra Connect 50mg is available from £9.19 following clinical assessment, whilst generic sildenafil options start from just 20% offering exceptional value for patients prioritising affordability. Avanafil pricing reflects its newer market entry and lack of generic alternatives, though the faster onset and improved tolerability profile justify the investment for many patients.

All PDE5 inhibitors require either a private prescription or completion of an online clinical assessment by a UK-registered prescriber, as mandated by MHRA regulations. Cured Pharmacy's transparent pricing model displays costs upfront before consultation, eliminating hidden fees that some online providers add at checkout. Our GPhC-registered pharmacy (9012511) dispenses only genuine UK-licensed medications, with discreet packaging and next-day delivery options available. New patients receive 20% off their first order using code Ednew, making trial of either medication more accessible whilst maintaining full clinical governance and safety standards.

Scientific References

1. Goldstein, I., et al. (2012). Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus. Mayo Clinic Proceedings, 87(9), 843-852. [accessed 18 August 2026]
2. Wang, R., et al. (2014). Avanafil for treatment of erectile dysfunction: a systematic review and meta-analysis. Urology, 83(2), 256-264. [accessed 18 August 2026]
3. Goldstein, I., et al. (2012). Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction: a phase III, randomized, double-blind, placebo-controlled trial. Journal of Sexual Medicine, 9(4), 1122-1133. [accessed 18 August 2026]
4. Eardley, I., et al. (2010). Pharmacotherapy for erectile dysfunction. Journal of Sexual Medicine, 7(1), 524-540. [accessed 18 August 2026]
5. Kyle, J. A., et al. (2013). Avanafil for erectile dysfunction: a review of the clinical data. Clinical Medicine Insights: Reproductive Health, 7, 1-14. [accessed 18 August 2026]
6. Corona, G., et al. (2016). The safety and efficacy of avanafil, a new 2nd generation PDE5i: comprehensive review and meta-analysis. Expert Opinion on Drug Safety, 15(2), 237-247. [accessed 18 August 2026]
7. European Medicines Agency. (2013). Spedra (avanafil): Summary of Product Characteristics. EMA. [accessed 18 August 2026]
8. Carson, C. C., & Lue, T. F. (2005). Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU International, 96(3), 257-280. [accessed 18 August 2026]
9. NHS. (2026). Erectile dysfunction (impotence). https://www.nhs.uk/conditions/erection-problems-erectile-dysfunction/ Accessed 18 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.